Molecule Details
| InChIKey | WRUQEVYKKCCSRY-ROAXINOMSA-N |
|---|---|
| Compound Name | (2S,3R,4R,5S,6R)-2-[3-[[4-[1-[(5S,6R)-5-amino-6-(2,5-difluorophenyl)oxan-3-yl]piperidin-4-yl]oxyphenyl]methyl]-4-ethylphenyl]-6-methylsulfanyloxane-3,4,5-triol |
| Canonical SMILES | CCc1ccc([C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(OC2CCN(C3CO[C@H](c4cc(F)ccc4F)[C@@H](N)C3)CC2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.87 |
| Source | BindingDB |
2D Structure
Activity Profile